AZ Hematology Hub

Featured Moments highlights of international experts' sessions captured in short videos.

Configure Paragraph Text Component

 

 

Precision Approach for CLL Management

Configure Image Component

CLL Management in Clinic

Dr. Ruba Taha, Qatar

Configure Image Component

CLL Risk Stratification

Dr. Kostas Stamatopoulos, Greece

Configure Image Component

Optimizing CLL Management

Dr. Salem Alshemmari, Kuwait

Configure Image Component

Translating Data into Practice

Dr. Ayman Ibrahim, Saudi Arabia

Configure Image Component

Panel Discussion

Dr. Feras Al Fraih, KSA

CLL Management 2023 - Year in Review

(26th February 2023)

Configure Image Component

Review on Time to Progression Regimen in CLL Management

Dr. George Follows, UK

Configure Image Component

The CLL Management in Clinic

Dr. Hani Osman, UAE

Configure Image Component

Translating Data Into Practice

Dr. Ihab El-Hemaidi, KSA

Configure Image Component

Review on Fixed Duration Regimen in CLL Management

Dr. Mahmoud Marashi, UAE

Configure Image Component

Panel Discussion

Dr. Feras Al Fraih, KSA

Applying guideline updates and real-world experience in CLL

Configure Image Component

CLL Case Presentation

Dr. Khalil Al Farsi, Oman

Configure Image Component

2nd GCC Haematology Forum- CLL Case Discussion Focus on Safety Profile of BTKi

Dr. Ruba Taha, Qatar

Configure Image Component

Expert Guidance for the Treatment of CLL

Dr. Susan M. O'Brien, US

Configure Image Component

Panel Discussion

Dr. Ayman Al Hejazi, KSA

EHA & ASCO updates in B-Cell malignancies

Configure Image Component

Panel Discussion

Dr. Ahmad Absi, KSA

Configure Image Component

Latest Updates in Management of CLL

Dr. Davide Rossi, Switzerland

Configure Image Component

CLL Management in Clinic

Dr. Faraz Khan, UAE

Configure Image Component

Translating Data Into Practise

Dr. Ramesh Pandita, Kuwait

Configure Image Component

Lates Updates in Management of Non-Hodgkin Lymphoma

Dr. Alfadel AL Shaibani, KSA

Precision approach for CLL treatment (26th June 2022)

Configure Image Component

Impact of Comorbidities and AEs on the Treatment Choice for CLL Patients

Dr. Ahmad Alhuraiji, Kuwait

Configure Image Component

CLL Management in Clinic

Dr. Aamer Aleem, KSA

Configure Image Component

How to Choose BTK Inhibitors for CLL Patients?

Dr. Krish Patel, US

Configure Image Component

Translating Data Into Practice

Dr. Shabeeha Rana, UAE

Configure Image Component

Panel Discussion

Dr. Amal Al-Beihany, KSA

High-risk CLL in the era of Novel Agents

Configure Image Component

Definition and Management of High-Risk CLL Patients

Dr. Ayman Al Hejazi, KSA

Configure Image Component

Continues Therapy Versus Time Limited Therapy in High-Risk CLL Patients

Dr. Wojciech Jurczak , Poland

Configure Image Component

Translating Data Into Practice

Dr. Iman Alhazmi, KSA

Configure Image Component

CLL Management in Clinic

Dr. Amar Lal, UAE

Configure Image Component

Panel Discussion

Dr. Arif Alam, UAE

Updates in Management of MCL

Configure Image Component

Translating Data Into Practice

Dr. Ghazi Alotaibi, KSA

Configure Image Component

Acalabrutinib and Other Novel Therapies in Mantle Cell Lymphoma

Dr. Michael Wang, US

Configure Image Component

MCL Management in Clinic

Dr. Salem Alshemmari, Kuwait

Configure Image Component

Management of Treatment Naïve Mantle Cell Lymphoma

Dr. Mustaqeem Siddiqui, UAE

Configure Image Component

Panel Discussion

Dr. Abdulaziz Hamadah, Kuwait

Adverse Events burden and management in 
CLL treatments (27th March 2022)

Configure Image Component

Optimizing the Usage of BTK Inhibitors in CLL

Dr. Cyrus Khan, US

Configure Image Component

CLL Management Inside the Clinic

Dr. Hassan Aljasem, KSA

Configure Image Component

Translating Data Into Practice

Dr. Husni Al Hateeti, UAE

Configure Image Component

Burden of Comorbidities & Adverse Events in CLL

Dr. Musa Al Zahrani, KSA

Configure Image Component

Panel Discussion

Dr. Amar Lal, UAE

BTKi review in management of CLL

Configure Image Component

Translating Data Into Clinical Practice

Dr. Abdulkareem Algarni, KSA

Configure Image Component

Critical Evaluation of BTKis in CLL

Dr. George Follows, UK

Configure Image Component

CLL Management Inside the Clinic

Dr. Hani Yousif Osman , UAE

Configure Image Component

Evolvement of CLL Management

Dr. Mahmoud Marashi, UAE

Configure Image Component

Panel Discussion

Dr. Ahmad Absi, KSA

Modal Window Component Section Begins
Modal Window Component Section Ends